Avadel Pharmaceuticals-adr Share Price: AVDL (Avadel Pharmaceuticals-adr) Stock Price Today & Updates | INDmoney

Question 1

What is Avadel Pharmaceuticals-adr share price today?

Accepted Answer

Avadel Pharmaceuticals-adr (AVDL) share price today is {{live_price}}.

Question 2

Can Indians buy Avadel Pharmaceuticals-adr shares?

Accepted Answer

Yes, Indians can invest in the Avadel Pharmaceuticals-adr (AVDL) from India.

With INDmoney, you can buy Avadel Pharmaceuticals-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Avadel Pharmaceuticals-adr at zero transaction cost.

Question 3

How can I buy Avadel Pharmaceuticals-adr shares from India?

Accepted Answer

It is very easy to buy Avadel Pharmaceuticals-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Avadel Pharmaceuticals-adr be purchased?

Accepted Answer

Yes, you can buy fractional shares of Avadel Pharmaceuticals-adr with INDmoney app.

Question 5

What are the documents required to start investing in Avadel Pharmaceuticals-adr stocks?

Accepted Answer

To start investing in Avadel Pharmaceuticals-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Avadel Pharmaceuticals-adr

Accepted Answer

Today’s highest price of Avadel Pharmaceuticals-adr (AVDL) is {{1_rba_end}}.

Today’s lowest price of Avadel Pharmaceuticals-adr (AVDL) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Avadel Pharmaceuticals-adr

Accepted Answer

Today's market capitalisation of Avadel Pharmaceuticals-adr AVDL is 1.4B

Question 8

What is the 52 Week High and Low Range of Avadel Pharmaceuticals-adr

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Avadel Pharmaceuticals-adr is down from its 52 Week High?

Accepted Answer

Avadel Pharmaceuticals-adr (AVDL) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Avadel Pharmaceuticals-adr is up from its 52 Week low?

Accepted Answer

Avadel Pharmaceuticals-adr (AVDL) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Avadel Pharmaceuticals-adr?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Avadel Pharmaceuticals-adr

Accepted Answer

Mr. Gregory J. Divis Jr. is the current Chief Executive Officer (CEO) of Avadel Pharmaceuticals-adr.

Period	Avadel Pharmaceuticals-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.64%	3.6%	0.0%
6 Months	-21.59%	10.2%	0.0%
1 Year	29.07%	19.6%	0.0%
3 Years	65.02%	16.8%	-23.0%

Market Capitalization	1.4B
Book Value	$0.73
Earnings Per Share (EPS)	-1.09
PEG Ratio	0.07
Wall Street Target Price	24.6

Profit Margin	-111.64%
Operating Margin TTM	-30.7%

Return On Assets TTM	-34.45%
Return On Equity TTM	-99.52%

Revenue TTM	95.1M
Revenue Per Share TTM	1.04
Quarterly Revenue Growth YOY	2674.2999999999997%
Gross Profit TTM	16.6M
EBITDA	-97.2M
Diluted Eps TTM	-1.09
Quarterly Earnings Growth YOY	0.0

Avadel Pharmaceuticals-adr (AVDL)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs CTLT

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.46
EPS Estimate Next Year	0.68
EPS Estimate Current Quarter	-0.16
EPS Estimate Next Quarter	-0.07

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avadel Pharmaceuticals-adr	5.4%	-21.59%	29.07%	65.02%	93.51%
Neurocrine Biosciences Inc.	0.22%	-11.71%	9.36%	13.47%	21.32%
Haleon Plc Spon Ads	-5.08%	20.69%	22.01%	36.17%	36.17%
Zoetis Inc.	-0.16%	32.8%	16.08%	-7.35%	52.85%
Viatris Inc.	2.53%	4.53%	31.84%	-16.06%	-28.03%
Catalent, Inc.	0.9%	7.56%	42.8%	-54.43%	23.98%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avadel Pharmaceuticals-adr	Buy	$1.4B	93.51%	NA	-111.64%
Neurocrine Biosciences Inc.	Buy	$11.9B	21.32%	35.55	16.0%
Haleon Plc Spon Ads	Buy	$45.6B	36.17%	32.52	9.66%
Zoetis Inc.	Buy	$87.6B	52.85%	37.9	26.29%
Viatris Inc.	Hold	$14.0B	-28.03%	224.4	-4.24%
Catalent, Inc.	Hold	$10.9B	23.98%	211.02	-23.81%

Organization	Avadel Pharmaceuticals-adr
Employees	154
CEO	Mr. Gregory J. Divis Jr.
Industry	Health Technology

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avadel Pharmaceuticals-adr	NA	NA	0.07	-0.46	-1.0	-0.34	NA	0.73
Neurocrine Biosciences Inc.	35.55	35.55	0.27	4.54	0.16	0.12	NA	24.87
Haleon Plc Spon Ads	32.52	32.52	1.5	0.39	0.07	0.04	0.02	1.82
Zoetis Inc.	37.9	37.9	2.64	5.83	0.49	0.14	0.01	10.94
Viatris Inc.	224.4	NA	0.07	2.67	-0.03	0.03	0.04	16.36
Catalent, Inc.	211.02	NA	3.02	0.2	-0.25	0.0	NA	19.91